Navneet Majhail: New complex blood cancer, HCT, and cellular therapy program at HCA Florida Healthcare North Florida
Navneet Majhail, Physician-in-Chief of Blood Cancers at Sarah Cannon Research Institute, shared a post on LinkedIn:
“Looking forward to welcoming our new complex blood cancer, HCT, and cellular therapy program at HCA Florida Healthcare North Florida Hospital to the Sarah Cannon Transplant and Cellular Therapy Network. The program will be a great resource for providing high-quality care to blood cancer patients in North Florida through the Sarah Cannon Cancer Network.
We will also be building a blood cancer, transplant, and cellular therapy clinical trial program in partnership with Sarah Cannon Research Institute. We are actively hiring for several colleagues to be a part of this exciting opportunity.”
Additional information
Source: Navneet Majhail/LinkedIn
Dr. Navneet Majhail, M.D., MS, FASTCT, is a Physician-in-Chief of Blood Cancers at the Sarah Cannon Transplant and Cellular Therapy Network. He is also the program medical director at the Sarah Cannon Transplant and Cellular Therapy Program at TriStar Centennial Medical Center in Nashville.His research centers on preventing and managing complications of blood and marrow transplantation, as well as health policy issues like disparities, quality of care, survivorship, and economic aspects of transplant.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023